Atopic Eczema
Conditions
Brief summary
This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.
Interventions
DRUGurea/lactic acid
new emulsion type
DRUGPlacebo
only emulsion base
Sponsors
ACO Hud Nordic AB
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Dry skin barrier disorders such as atopic dermatitis or Malassezia eradicated head and neck dermatitis. * Rough or clinically normal skin on the volar aspect of the forearm. * Either gender * Age between 18 and 65 years * Written Informed Consent
Exclusion criteria
* Possible allergy to ingredients in the study medications. * Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy. * Any patient related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse). * Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results. * Pregnancy or breast feeding, or patients who plan to become pregnant during the course of the study.
Countries
Sweden
Contacts
Primary ContactLena Holm, Dr
Outcome results
None listed